Chimerix competitors

Zippia score 4.0

Chimerix main competitors are BioMarin, BioCryst Pharmaceuticals, and Insmed.

Competitor Summary. See how Chimerix compares to its main competitors:

BioMarin has the most employees (2,581).
Employees at BioMarin earn more than most of the competitors, with an average yearly salary of $87,259.

Work at Chimerix?

Share your experience

Chimerix vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Chimerix	2000	4.0	Durham, NC	1	$212,000	82
Vical	1987	3.5	San Diego, CA	1	$12.4M	213
BioCryst Pharmaceuticals	1986	4.8	Durham, NC	2	$450.7M	110
Raptor Pharmaceuticals	-	4.0	Novato, CA	1	-	125
PDL BioPharma	1986	4.2	Incline Village, NV	1	$30.7M	75
BioMarin	1997	4.6	San Rafael, CA	4	$2.9B	2,581
Insmed	1988	4.9	Bridgewater, NJ	1	$363.7M	373

Rate Chimerix's competitiveness in the market.

Chimerix salaries vs competitors

Among Chimerix competitors, employees at BioMarin earn the most with an average yearly salary of $87,259.

Compare Chimerix salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Chimerix	$45,614	$21.93	-
Vical	$75,394	$36.25	-
BioCryst Pharmaceuticals	$85,535	$41.12	-
PDL BioPharma	$48,962	$23.54	-
BioMarin	$87,259	$41.95	-
Insmed	$81,784	$39.32	-

Compare Chimerix job title salaries vs competitors

Company	Highest salary	Hourly salary
Chimerix	$32,157	$15.46
BioMarin	$42,626	$20.49
BioCryst Pharmaceuticals	$42,017	$20.20
Insmed	$36,840	$17.71
PDL BioPharma	$32,905	$15.82
Vical	$32,485	$15.62
Raptor Pharmaceuticals	$32,077	$15.42

Do you work at Chimerix?

Is Chimerix able to compete effectively with similar companies?

Chimerix jobs

Chimerix demographics vs competitors

Compare gender at Chimerix vs competitors

Job title	Male	Female
Chimerix	35%	65%
PDL BioPharma	46%	54%
BioMarin	50%	50%

Male

Female

100%

75%

50%

25%

BioMarin

PDL BioPharma

Chimerix

25%

50%

75%

100%

Compare race at Chimerix vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Chimerix	62%	11%	16%	5%	5%	6.9
BioMarin	43%	20%	8%	23%	7%	9.6
PDL BioPharma	54%	15%	7%	19%	4%	9.3

Chimerix revenue vs competitors

Chimerix and similar companies CEOs

CEOBio

Jon P. Stonehouse

BioCryst Pharmaceuticals

Jon P. Stonehouse, a pharmaceutical executive for more than 20 years, has strong commercialization, financial transaction, business development and management expertise. He most recently served as Senior Vice President of Corporate Development at Merck KGaA with responsibility for global licensing and business development, corporate mergers and acquisitions, corporate strategic planning and alliance management. Among his accomplishments, he was responsible for leading the effort to develop a strategy for Merck that significantly changed the company. This culminated with the acquisition of Serono, S.A., the largest biotechnology company in Europe at the time of the agreement.

Jean Jacques Bienaime

BioMarin

Jean-Jacques Bienaime is a Board Member at Biotechnology Innovation Organization - BIO, Director at INCYTE CORP, and Chairman/CEO at BioMarin Pharmaceutical Inc and is based in Novato, California. He has experience at Rhône Poulenc Rorer and has worked as President/CEO at GENENCOR INTERNATIONAL INC, Board Member at NeurogesX Inc, and Marketing Director at Genentech. Jean attended ESCP Europe, Ecole Superieure de Commerce de Paris between 1974 and 1976, and University of Pennsylvania.

William H. Lewis J.d

Insmed

Christopher Stone

PDL BioPharma

Vijay Samant

Vical

Vijay Samant is a Board Member at Brickell Biotech Inc. He has worked as President/CEO at Vical; Trustee at International Vaccine Institute (IVI); and VP:Vaccine/Exec Dir:Materials Mgmt at MERCK & CO., INC.. Vijay studied at Columbia University, University of Mumbai, and MIT Sloan.